NASDAQ

Lexicon Pharmaceuticals, Inc. (LXRX)

♥ 475 Thanks from members

Live price chart, market sentiment, and community perspectives for Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Alan SandsFounder: Arthur T. SandsLeadership: Lonnel Coats (CEO)Leadership: Jeffrey R. Wade (President and CFO)Holder: Baker Bros. Advisors LPHolder: The Vanguard GroupHolder: BlackRock, Inc.Inpefa (sotagliflozin)Telotristat ethylXermelo#LXRX#Lexicon Pharmaceuticals#biotech stock#gene science#Inpefa